Reference no: EM132737464
Coronavirus disease 2019 (COVID-19) is a contagious respiratory and vascular disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Common symptoms include fever, cough, fatigue, breathing difficulties, and loss of smell and taste. Symptoms begin one to fourteen days after exposure to the virus.
While most people have mild symptoms, some people develop acute respiratory distress syndrome (ARDS), which can be precipitated by cytokine storms, multi-organ failure, septic shock, and blood clots. Longer-term damage to organs (in particular, the lungs and heart) has been observed, and there is concern about a significant number of patients who have recovered from the acute phase of the disease but continue to experience a range of effects-known as long COVID-for months afterwards, including severe fatigue, memory loss and other cognitive issues, low grade fever, muscle weakness, and breathlessness.
According to the announcement from Centers for Disease Control and Prevention in US, people with high risk to develop serious symptoms are adults who are 65 years and older and also adults with chronic health conditions (e.g., asthma, heart disease, stroke, diabetes, and chronic kidney disease).
Pfizer Inc., an American multinational pharmaceutical corporation, and its partner BioNTech announced that their vaccine against Covid-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement - and relief - in the face of the global pandemic. However, how to manufacture enough dozes of Covid-19 vaccines within a very limited time to meet the large demand for the vaccine remains an issue.
If you were the CEO of Pfizer Inc, would you ensure that all your employees were inoculated first, or would you recommend that they too wait in line?
Requirements:
1. From a utilitarian point of view, explain why your decision is an ethical decision.
2. From a justice as fairness perspective, explain why your decision is an ethical decision.